“Appropriate Utilization of the Prognostic 40-Gene Expression Profile (40-GEP) Test for Cutaneous Squamous Cell Carcinoma (cSCC) Demonstrated by Clinical Reports and Physician Evaluation of Real-World Cases”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 2, Mar. 2022, p. s21, https://doi.org/10.25251/skin.6.supp.21.